Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Nine-month angiographic and intravascular ultrasound outcomes after resolute zotarolimus-eluting stent implantation for the treatment of in-stent restenosis.

Lee SY, Kim BK, Kim JS, Hong MK, Cho DK, Yoon J, Jeon DW, Lee NH, Kwon HM, Jang Y.

J Interv Cardiol. 2013 Dec;26(6):543-9. doi: 10.1111/joic.12073. Epub 2013 Oct 24. Erratum in: J Interv Cardiol. 2014 Feb;27(1):96.

PMID:
24308658
[PubMed - indexed for MEDLINE]
2.

Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.

Richardt G, Leschke M, Abdel-Wahab M, Toelg R, El-Mawardy M, Serruys PW, Silber S, Windecker S, Belardi JA, Neumann FJ, Widimsky P; RESOLUTE All Comers; RESOLUTE International Investigators.

JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14.

PMID:
23954063
[PubMed - indexed for MEDLINE]
Free Article
3.

Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.

Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2014 May 1;83(6):873-8. doi: 10.1002/ccd.24560. Epub 2013 Nov 9.

PMID:
22815193
[PubMed - indexed for MEDLINE]
4.

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.

Jensen LO, Maeng M, Thayssen P, Villadsen A, Krusell L, Botker HE, Pedersen KE, Aaroe J, Christiansen EH, Vesterlund T, Hansen KN, Ravkilde J, Tilsted HH, Lassen JF, Thuesen L.

EuroIntervention. 2011 Jul;7(3):323-31. doi: 10.4244/EIJV7I3A56.

PMID:
21729834
[PubMed - indexed for MEDLINE]
Free Article
5.

Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial.

Xu B, Yang Y, Yuan Z, Du Z, Wong SC, Généreux P, Lu S; RESOLUTE China RCT Investigators.

JACC Cardiovasc Interv. 2013 Jul;6(7):664-70. doi: 10.1016/j.jcin.2013.03.001. Epub 2013 Mar 21.

PMID:
23523240
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.

Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ; ENDEAVOR III Investigators.

Am Heart J. 2008 Jan;155(1):108-13. Epub 2007 Sep 14.

PMID:
18082499
[PubMed - indexed for MEDLINE]
7.

Angiographic and intravascular ultrasound findings following implantation of the Endeavor zotarolimus-eluting stents in patients from the real-world clinical practice.

Feres F, Andrade PB, Costa RA, de Ribamar Costa J Jr, Abizaid A, Staico R, Tanajura LF, Siqueira D, Maia JP, Lasave L, Sousa AG, Sousa JE.

EuroIntervention. 2009 Aug;5(3):355-62.

PMID:
19736161
[PubMed - indexed for MEDLINE]
9.

Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Kim JS, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Aug;28(6):1281-7. doi: 10.1007/s10554-011-9943-x. Epub 2011 Aug 21.

PMID:
21858655
[PubMed - indexed for MEDLINE]
10.

Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators.

JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015.

PMID:
19695548
[PubMed - indexed for MEDLINE]
Free Article
11.

Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea.

Lee JM, Youn TJ, Park JJ, Oh IY, Yoon CH, Suh JW, Cho YS, Cho GY, Chae IH, Choi DJ.

BMC Cardiovasc Disord. 2013 Sep 8;13:65. doi: 10.1186/1471-2261-13-65.

PMID:
24011332
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial.

Ahn JM, Park DW, Kim YH, Song H, Cho YR, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Han S, Lee SY, Lee BK, Cho JH, Yang TH, Lee NH, Yang JY, Park JS, Shin WY, Kim MH, Bae JH, Kim MK, Yoon J, Park SJ.

Circ Cardiovasc Interv. 2012 Oct;5(5):633-40. doi: 10.1161/CIRCINTERVENTIONS.111.965673. Epub 2012 Oct 9.

PMID:
23048051
[PubMed - indexed for MEDLINE]
Free Article
13.

Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(12):1-97. Epub 2006 Apr 1.

PMID:
23074482
[PubMed]
Free PMC Article
14.

Coronary arterial remodeling and out-stent plaque change after drug-eluting stent implantation--comparison between zotarolimus-eluting stents and paclitaxel-eluting stents.

Muraoka Y, Sonoda S, Kashiyama K, Kamezaki F, Tsuda Y, Araki M, Tamura M, Takeuchi M, Abe H, Okazaki M, Otsuji Y.

Circ J. 2013;77(2):363-71. Epub 2012 Oct 27.

PMID:
23117679
[PubMed - indexed for MEDLINE]
Free Article
15.

4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).

Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, Buszman PE, Kelbaek H, Windecker S; RESOLUTE All-Comers Investigators.

J Am Coll Cardiol. 2014 Apr 29;63(16):1617-25. doi: 10.1016/j.jacc.2013.12.036. Epub 2014 Feb 13.

PMID:
24530680
[PubMed - indexed for MEDLINE]
16.

Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.

Kim S, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Cho YK, Nam CW, Hur SH, Jang Y, Hong MK.

Am J Cardiol. 2013 Jan 1;111(1):1-5. doi: 10.1016/j.amjcard.2012.08.037. Epub 2012 Oct 2. Erratum in: Am J Cardiol. 2013 Sep 1;112(5):746.

PMID:
23040589
[PubMed - indexed for MEDLINE]
17.

Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.

Kang SJ, Cho YR, Park GM, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Mintz GS, Park SW, Park SJ.

Am J Cardiol. 2013 May 15;111(10):1408-14. doi: 10.1016/j.amjcard.2013.01.288. Epub 2013 Feb 20.

PMID:
23433757
[PubMed - indexed for MEDLINE]
18.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.

PMID:
24055443
[PubMed - indexed for MEDLINE]
Free Article
19.

Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.

Ando H, Amano T, Takashima H, Harada K, Kitagawa K, Suzuki A, Kunimura A, Shimbo Y, Harada K, Yoshida T, Kato B, Uetani T, Kato M, Matsubara T, Kumagai S, Yoshikawa D, Isobe S, Ishii H, Murohara T.

Eur Heart J Cardiovasc Imaging. 2013 Oct;14(10):996-1001. doi: 10.1093/ehjci/jet003. Epub 2013 Jan 22.

PMID:
23341147
[PubMed - indexed for MEDLINE]
20.

Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.

Koizumi T, Fitzgerald PJ, Honda Y, Ellis SG, Kent K, Martin SL, Brown CL, Masud AR, Patterson JB, Greenberg J, Friedman M, Uchida T, Stone GW.

Cardiovasc Revasc Med. 2010 Jul-Sep;11(3):140-8. doi: 10.1016/j.carrev.2009.07.004.

PMID:
20599163
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk